Rabeprazole Sodium

CAS 117976-90-6 18 current records 14 historicalSmall Molecule

Who holds supplier records for Rabeprazole Sodium? 18 organisations hold a current record for Rabeprazole Sodium: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), Spain (2), Taiwan (1), China (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rabeprazole Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rabeprazole-sodium

Reading the evidence

  • 18 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 17 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (18)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rabeprazole Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India12Spain2Taiwan1China1Slovenia1Country not recorded for 1
Need Rabeprazole Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Rabeprazole Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2020-382 - Rev 02
Rabeprazole sodium hydrate, Form-Y (RBL process)
Sept 2026—
NIFTY LABS PRIVATE LIMITED HyderabadIN
CEP 2020-166 - Rev 04
Rabeprazole sodium hydrate
Aug 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2018-158 - Rev 02
Rabeprazole sodium hydrate
Mar 2026—
KRKA, d.d., Novo mesto Novo mestoSI
CEP 2018-140 - Rev 02
Rabeprazole sodium hydrate
Feb 2025Inspected Jul 2025
Slovenia
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2019-173 - Rev 04
Rabeprazole sodium hydrate, Form Y
Nov 2024Inspected Apr 2025
Spain
METROCHEM API PRIVATE LIMITED HyderabadIN
CEP 2022-468 - Rev 01
Rabeprazole sodium hydrate, Y-Form
Jun 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2017-253 - Rev 01
Rabeprazole sodium hydrate
Dec 2023—
SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang CityCN
R0-CEP 2021-463 - Rev 00
Rabeprazole sodium hydrate
May 2023—
Moehs Iberica S.L. RubiES
R1-CEP 2017-014 - Rev 00
Rabeprazole sodium hydrate
Apr 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (14)

Organisations whose Type II DMFs for Rabeprazole Sodium are no longer active. These show a past filing, not current supply.

Show all 14 historical records
  • SHANGHAI SINE PHARMACEUTICAL LABORATORIES CO LTD
    Inactive DMF 27225 · filed Jun 2013
  • India · Inactive DMF 25320 · filed Oct 2011
  • India · Inactive DMF 24973 · filed May 2011
  • India · Inactive DMF 24830 · filed Apr 2011
  • SINTENOVO SA DE CV
    Inactive DMF 23907 · filed Jun 2010
  • CHEMO IBERICA SA MADRID
    Inactive DMF 21585 · filed Apr 2008
  • UQUIFA MEXICO SA DE CV
    Inactive DMF 21495 · filed Apr 2008
  • RANBAXY LABORATORIES LTD
    Inactive DMF 21205 · filed Dec 2007
  • India · Inactive DMF 21192, 18226 · filed Dec 2007
  • MYLAN LABORATORIES LTD
    Inactive DMF 21203 · filed Dec 2007
  • India · Inactive DMF 21034 · filed Oct 2007
  • Amino Chemicals Ltd
    Malta · Inactive DMF 20818 · filed Aug 2007
  • India · Inactive DMF 19903 · filed Oct 2006
  • India · Inactive DMF 16764 · filed Aug 2003

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rabeprazole Sodium is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cell. It is widely used in the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers and Zollinger-Ellison syndrome.

Chemical identity

IUPAC name
sodium 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ide
Canonical SMILES
CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]
InChIKey
KRCQSTCYZUOBHN-UHFFFAOYSA-N
Synonyms
Aciphex API, aciphex, e-3810 sodium, idiazole, ly-307640 sodium, ly307640 sodium, nsc-759270, pariet, rabeprazole na, rabeprazole sodium salt, sodium rabeprazole

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Proton Pump Inhibitor
Mechanism of action
Proton Pump Inhibitors

Therapeutic areas

Gastroenterology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rabeprazole Sodium?

18 organisations hold an active US FDA Type II Drug Master File or a CEP for Rabeprazole Sodium: Dr. Reddy's Laboratories Ltd. (India), METROCHEM API PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), MOEHS IBERICA SL (Spain), QUIMICA SINTETICA SA (Spain), Alkem Laboratories Limited (India), JUBILANT BIOSYS LTD (India) and Macleods Pharmaceuticals Ltd. (India), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rabeprazole Sodium Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 16747, 22031), METROCHEM API PRIVATE LTD (DMF 37630, 35344), APITORIA PHARMA PRIVATE LTD (DMF 19186), MOEHS IBERICA SL (DMF 24924), QUIMICA SINTETICA SA (DMF 25309), Alkem Laboratories Limited (DMF 27403), JUBILANT BIOSYS LTD (DMF 22338) and Macleods Pharmaceuticals Ltd. (DMF 25711) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rabeprazole Sodium records mean?

14 organisations have only inactive Type II DMFs for Rabeprazole Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Rabeprazole Sodium have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Rabeprazole Sodium on the EDQM register, including DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), NIFTY LABS PRIVATE LIMITED Hyderabad (IN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN), KRKA, d.d., Novo mesto Novo mesto (SI), QUIMICA SINTETICA S.A. Alcala De Henares (ES) and METROCHEM API PRIVATE LIMITED Hyderabad (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rabeprazole Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rabeprazole Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.